Target $120 on Buy-Rated Sinopec

Tags: snp
30 Aug 2:29am
Read original blog entry


While we track several of the strongest Chinese companies for investors looking to increase their exposure to the world's fastest-growing economy, we excerpt a few notes from the latest Buy report on Sinopec (SNP) by Zacks senior Chinese market analyst Paul Cheung, CFA:


'Sinopec recently reported strong interim results for the first half of 2007. While a number of uncertainties remain, we believe that the near- to medium-term environment supports its continued upstream production growth and downstream capacity expansion.


'Moreover, Sinopec's integrated petrochemical and refining businesses are expected to benefit from possible price reform for refined products in China. Therefore, we are maintaining our Buy recommendation on Sinopec.


'Currently, SNP ADRs are trading at 12.0x our 2007 earnings estimate, lower than its global and Chinese peers. SNP ADRs are also trading at 10.9x our 2008 earnings estimate, still lower than its global and Chinese peers. Given the company's good position to leverage China's strong economic growth, we see upside potential from current levels. Our $120.00 price objective reflects a P/E multiple of 11.8x our 2008 earnings estimate.'


Read the full analyst report on SNP


Get real-time market insights and profitable stock recommendations from the team of analysts at Zacks Equity Research. See all today’s Analyst Blog entries on Zacks.com.

Comments

Back to top

Post comment

Back to top

Post a comment

Please login to post a comment

About

ZacksResearch

Zacks Investment Research is one of the most highly regarded firms in the investment industry. Our firm has long believed that that quantitative models (like the Zacks Rank) can predict stock prices more accurately than individual analysts. However we also recognize that models are most effective when they are employed by analysts who have deep fundamental knowledge of the company and its industry. Consequently Zacks Equity Research combines Zacks quantitative models with the insight provided by an experienced team of 50 analysts to create superior long term stock recommendations. Discover all their timely insight and recommendations daily on Zacks.com.